Treating Major Depression With Yoga Mono-therapy
Recruiting · NCT06091527 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
EducationYoga practice
What this trial is about
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 18 years of age or older
- Able to give voluntary, informed consent
- English-speaking
- Diagnosis of clinical depression
Exclusion criteria
- Current use of antidepressant medication
- Current engagement in psychotherapy
- Current pregnancy
- Significant medical issues interfering with yoga practice
Where it is running
1 location listed across 1 US state.
- Zuckerberg San Francisco General Hospital - San Francisco, California, United States